Richard Fisher - Tenet Healthcare Independent Director
THC Stock | USD 142.68 0.70 0.49% |
Director
Mr. Richard W. Fisher is Independent Director of the Company. Mr. Fisher served as President and Chief Executive Officer of the Federal Reserve Bank of Dallas from 2005 until 2015. During his tenure, he served as a member of the Federal Open Market Policy Committee, as the chair of the Conference of Federal Reserve Bank Presidents, and as the chair of the Information Technology Oversight Committee for the 12 Federal Reserve banks. Previously, from 2001 to 2005, Mr. Fisher was Vice Chairman of Kissinger McLarty Associates, a strategic advisory firm. From 1997 to 2001, Mr. Fisher served as Deputy U.S. Trade Representative with the rank of Ambassador. Mr. Fisher currently serves as a Senior Advisor for Barclays PLC, a leading investment bank, and as a Trustee of the University of Texas Southwestern Medical Foundation since 2017.
Age | 72 |
Tenure | 7 years |
Professional Marks | MBA |
Address | 14201 Dallas Parkway, Dallas, TX, United States, 75254 |
Phone | 469 893 2200 |
Web | https://www.tenethealth.com |
Richard Fisher Latest Insider Activity
Tracking and analyzing the buying and selling activities of Richard Fisher against Tenet Healthcare stock is an integral part of due diligence when investing in Tenet Healthcare. Richard Fisher insider activity provides valuable insight into whether Tenet Healthcare is net buyers or sellers over its current business cycle. Note, Tenet Healthcare insiders must abide by specific rules, including filing SEC forms every time they buy or sell Tenet Healthcare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Richard Fisher over six months ago Acquisition by Richard Fisher of 1551 shares of Tenet Healthcare subject to Rule 16b-3 |
Tenet Healthcare Management Efficiency
The company has Return on Asset of 0.0699 % which means that on every $100 spent on assets, it made $0.0699 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5956 %, implying that it generated $0.5956 on every 100 dollars invested. Tenet Healthcare's management efficiency ratios could be used to measure how well Tenet Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.04. The current year's Return On Capital Employed is expected to grow to 0.12. At present, Tenet Healthcare's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 214.4 M, whereas Intangible Assets are forecasted to decline to about 1.3 B.Similar Executives
Showing other executives | DIRECTOR Age | ||
NancyAnn DeParle | HCA Holdings | 64 | |
Donald Correll | Encompass Health Corp | 70 | |
Warren Nimetz | Universal Health Services | 64 | |
Parvinderjit Khanuja | Select Medical Holdings | 62 | |
Mark Brookner | US Physicalrapy | 76 | |
Lawrence Gibbs | Universal Health Services | 48 | |
Daphne Jones | AMN Healthcare Services | 64 | |
Charles Elson | Encompass Health Corp | 60 | |
Robert Dennis | HCA Holdings | 67 | |
Reginald Swanson | US Physicalrapy | 67 | |
Mark Foletta | AMN Healthcare Services | 60 | |
Elliot Sussman | Universal Health Services | 68 | |
Katherine Davisson | Select Medical Holdings | 53 | |
Clayton Trier | US Physicalrapy | 69 | |
Meg Crofton | HCA Holdings | 67 | |
John Maupin | Encompass Health Corp | 73 | |
Phyllis Yale | DaVita HealthCare Partners | 62 | |
Christopher Reidy | Encompass Health Corp | 64 | |
Paul Diaz | DaVita HealthCare Partners | 58 | |
Bryan Cressey | Select Medical Holdings | 71 | |
Bernard Harris | US Physicalrapy | 64 |
Management Performance
Return On Equity | 0.6 | ||||
Return On Asset | 0.0699 |
Tenet Healthcare Leadership Team
Elected by the shareholders, the Tenet Healthcare's board of directors comprises two types of representatives: Tenet Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tenet. The board's role is to monitor Tenet Healthcare's management team and ensure that shareholders' interests are well served. Tenet Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tenet Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Johnston, Chief USPI | ||
Meghan FitzGerald, Independent Director | ||
Bill Durham, Chief Network | ||
Christopher Lynch, Independent Director | ||
Cecil Haney, Independent Director | ||
Nadja West, Independent Director | ||
Liz Johnson, Chief Officer | ||
Richard Fisher, Independent Director | ||
Paola Arbour, Executive Vice President, Chief Information Officer | ||
William III, Vice Relations | ||
Howard Hacker, Executive Vice President, Chief Compliance Officer | ||
Lloyd Austin, Independent Director | ||
Richard Mark, Independent Director | ||
J Kerrey, Lead Independent Director | ||
Lisa Foo, Executive Vice President - Commercial Operations | ||
Tammy Romo, Independent Director | ||
Sun Park, Executive CFO | ||
Saumya Sutaria, President, Chief Executive Officer, Chief Operating Officer, Director | ||
Michael Maloney, Executive Development | ||
James Bierman, Independent Director | ||
Thomas Arnst, Executive Vice President, Chief Administrative Officer, General Counsel, Corporate Secretary | ||
Daniel Cancelmi, Chief Financial Officer, Executive Vice President | ||
Saumya MD, CEO and President | ||
Sandra Karrmann, Chief Human Resource Officer, Executive Vice President | ||
Audrey Andrews, Executive Vice President, General Counsel, Corporate Secretary | ||
Ronald Rittenmeyer, Executive Chairman of the Board, Chief Executive Officer | ||
Marie Quintana, Executive Vice President - Communications, Chief Marketing Officer | ||
Jana Durfee, Senior Officer | ||
Clint Hailey, Chief VP |
Tenet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tenet Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.6 | ||||
Return On Asset | 0.0699 | ||||
Profit Margin | 0.15 % | ||||
Operating Margin | 0.14 % | ||||
Current Valuation | 22.35 B | ||||
Shares Outstanding | 95.1 M | ||||
Shares Owned By Insiders | 1.16 % | ||||
Shares Owned By Institutions | 96.77 % | ||||
Number Of Shares Shorted | 2.08 M | ||||
Price To Earning | 11.95 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tenet Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenet Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenet Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenet Healthcare Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenet Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Tenet Stock refer to our How to Trade Tenet Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenet Healthcare. If investors know Tenet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenet Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.215 | Earnings Share 31.58 | Revenue Per Share 213.204 | Quarterly Revenue Growth 0.011 | Return On Assets 0.0699 |
The market value of Tenet Healthcare is measured differently than its book value, which is the value of Tenet that is recorded on the company's balance sheet. Investors also form their own opinion of Tenet Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tenet Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenet Healthcare's market value can be influenced by many factors that don't directly affect Tenet Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenet Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenet Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenet Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.